CYP2C19 and ischemic stroke: <h4>Objective</h4>To evaluate the effectiveness and safety of an antiplatelet therapy strategy guided by CYP2C19 genotyping in the secondary prevention of ischemic stroke in a real-world setting.<h4>Methods</h4>This single-center retrospective cohort study enrolled 623 ischemic stroke patients.